Revenue: The sum of all revenue fields included for a company's operating activities.
Arch Therapeutics, Inc. (ARTHQ) had Revenue of $0.03M for the most recently reported fiscal quarter, ending 2024-06-30.
Income Statement Financials | |
Revenue |
$0.03M |
$-6.38M |
|
$0.02M |
|
$0.01M |
|
$1.05M |
|
$-1.02M |
|
$-4.63M |
|
$-5.65M |
|
$-5.65M |
|
$-5.65M |
|
$-5.65M |
|
$-5.65M |
|
$-5.65M |
|
$-1.02M |
|
$-1.02M |
|
4.44M |
|
4.44M |
|
$-1.44 |
|
$-1.44 |
|
Balance Sheet Financials | |
$1.39M |
|
$0.00M |
|
$0.01M |
|
$1.40M |
|
$13.96M |
|
-- |
|
-- |
|
$13.96M |
|
$-12.56M |
|
$-12.56M |
|
$-12.56M |
|
4.44M |
|
Cash Flow Statement Financials | |
$-2.47M |
|
$0.00M |
|
$2.28M |
|
$0.22M |
|
$0.03M |
|
$-0.19M |
|
$0.04M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-- |
|
-0.75 |
|
31.81% |
|
-3304.36% |
|
-3304.36% |
|
-- |
|
-18292.24% |
|
-20653.71% |
|
$-2.47M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
-- |
|
-- |
|
45.02% |
|
45.02% |
|
-404.59% |
|
45.02% |
|
$-2.83 |
|
$-0.56 |
|
$-0.56 |